Why IMU is a multi multi bagger, page-21207

Sentiment is quite low for all bio stocks at the moment, this may be just due to uncertainty with the economy, and interest rates.
Imugene has always been a hard sell with no income or deals in the wings, despite showing amazing promise and already great results from current trials.
All stocks of this make-up require some form of catalyst to move individuals and institutions to invest in them, and while all looks very promising the reality is we have not seen that catalyst and there are no near term opportunities for that to occur, in the way of trial results or interest from BP.
Patience is a very difficult quality that ebbs and flows within the Investor and now more than ever many of us are digging deep to find some within ourselves, while we all want near term gratification it will not come by wishing it.
Time to give hc a rest as this only serves magnify this impatience, many things outside of this world are far more important.

DYOR opinion only